Erythropoietin News and Research

RSS
Erythropoietin, or its alternative erythropoetin or EPO, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine for erythrocyte (red blood cell) precursors in the bone marrow.
Acceleron commences ACE-536 phase 2 study in beta-thalassemia

Acceleron commences ACE-536 phase 2 study in beta-thalassemia

Acceleron commences ACE-536 phase 2 study in myelodysplastic syndromes

Acceleron commences ACE-536 phase 2 study in myelodysplastic syndromes

Paper says hospitals that do treat patients with anemia have better outcomes

Paper says hospitals that do treat patients with anemia have better outcomes

NOXXON commences NOX-H94 Phase IIa trial to treat anemia of chronic disease

NOXXON commences NOX-H94 Phase IIa trial to treat anemia of chronic disease

Medgenics’ EPODURE Biopump technology for EPO delivery receives U.S. patent

Medgenics’ EPODURE Biopump technology for EPO delivery receives U.S. patent

United States Pharmacopeial Convention to host Fifth Bioassay Workshop in Rockville

United States Pharmacopeial Convention to host Fifth Bioassay Workshop in Rockville

Takeda, Affymax announce data from OMONTYS Phase 3 studies on anemia due to CKD

Takeda, Affymax announce data from OMONTYS Phase 3 studies on anemia due to CKD

Pleiotrophin protein may be long-sought growth factor for blood stem cells

Pleiotrophin protein may be long-sought growth factor for blood stem cells

Positive results from PROLOR's Rpeg preclinical toxicology study

Positive results from PROLOR's Rpeg preclinical toxicology study

Multiple Epo doses with hypothermia offers neonate neuroprotection

Multiple Epo doses with hypothermia offers neonate neuroprotection

Scripps scientists discover new antibody-discovery technique

Scripps scientists discover new antibody-discovery technique

Israel's Ministry of Health approves Medgenics’ INFRADURE Phase I/II clinical trials for hepatitis C

Israel's Ministry of Health approves Medgenics’ INFRADURE Phase I/II clinical trials for hepatitis C

Researchers uncover protein structure that regulates blood cell formation and activity

Researchers uncover protein structure that regulates blood cell formation and activity

Two cellular proteins team up to provide steady supply of RBCs

Two cellular proteins team up to provide steady supply of RBCs

PROLOR to present data on long-acting clotting factors for hemophilia at WFH World Congress

PROLOR to present data on long-acting clotting factors for hemophilia at WFH World Congress

Lessons learned from transfusion refusal

Lessons learned from transfusion refusal

Jehovah’s Witnesses’ beliefs do not necessarily put them at risk

Jehovah’s Witnesses’ beliefs do not necessarily put them at risk

FDA grants Orphan Drug Designation to Medgenics’ INFRADURE Biopump

FDA grants Orphan Drug Designation to Medgenics’ INFRADURE Biopump

Acute and chronic elevation of EPO in the brain improve motivation for exercise

Acute and chronic elevation of EPO in the brain improve motivation for exercise

Medgenics’ EPODURE receives FDA clearance to proceed into clinical trials

Medgenics’ EPODURE receives FDA clearance to proceed into clinical trials